Live
- DMHO Dr. Swarajya Lakshmi conducted patient check-ups in the doctor’s absence during an inspection
- Hamid Ali Appointed as Public Prosecutor for Nagar Kurnool District Court
- Mathematics Day Celebrations Held Grandly at Government Science Degree College
- Maharashtra ‘foul deaths’: Grim Sharad Pawar meets kin of Beed Sarpanch, Parbhani Dalit man
- Golden Chariot Luxury Train Revived
- Trying to deflect attention from AAP's failure: JD(U) leader on Kejriwal's letter to CM Nitish
- Advertising Club Hyderabad organises Seminar
- Rahul Gandhi more suitable to be a gym trainer: Acharya Pramod Krishnam
- PM Modi meets 101-year-old former IFS officer, gets a rousing welcome in Kuwait
- Mindful Goddesses: How Women’s Spiritual Development Is Strengthened by Meditation
27% Indians have high cholesterol levels: Study
This World Heart Day, Ranbaxy Laboratories Ltd released the findings of a pan-India study, revealing that more than 27 per cent of patients with one or more cardiovascular risk factors had high levels of bad cholesterol (LDL> 130 mg/dL) while 42.8 per cent had elevated blood triglycerides (TG > 150 mg/ dL). Highlighting the mounting prevalence of dyslipidemia (abnormal amounts of lipids in blood) in Indians, the study was conducted on patients who visited the clinic during the study period.
On World Heart Day, Ranbaxy releases the findings of a pan-India study which reveals the growing prevalence of dyslipidemia in India
This World Heart Day, Ranbaxy Laboratories Ltd released the findings of a pan-India study, revealing that more than 27 per cent of patients with one or more cardiovascular risk factors had high levels of bad cholesterol (LDL> 130 mg/dL) while 42.8 per cent had elevated blood triglycerides (TG > 150 mg/ dL). Highlighting the mounting prevalence of dyslipidemia (abnormal amounts of lipids in blood) in Indians, the study was conducted on patients who visited the clinic during the study period.
Dr PA Jiwani, a Hyderabad-based cardiologist, explains, “Needless to say, the challenges in curbing the burden of cardio-vascular diseases (CVD) in India are multifaceted. Sedentary lifestyles, eating patterns, lack of regular physical activity and non-compliance to therapy when diagnosed with dyslipidemia have led to a steep rise in the number of people suffering from CVD. While India is already known as the diabetic capital of the world, at this rate we would soon have the highest global incidence of CVD. Unfortunately, there is a lack of published reports on Indian patients, which is a roadblock for doctors when it comes to creating awareness among people about the risks of heart disease.”
To bridge this gap, Ranbaxy facilitated this study as part of its novel ‘Fit Heart Movement’. By conducting awareness campaigns, population studies and prevention camps, the ‘Fit Heart Movement’ focuses on increasing awareness to prevent CVDs in India by early diagnosis and patient education.
The study put the spotlight on regional variation in dyslipidemia prevalence and cardiovascular risk assessment. It covered a total of 46,919 patients from 212 cities across India with one or more cardiovascular risk factors like diabetes, hypertension, family history of chronic heart disease, smokers and people aged 50 and above. Among the other findings, the study also revealed that 28 per cent of the people had elevated total cholesterol (TC >200 mg/ dL) and 41 per cent had low levels of good cholesterol (HDL < 40 mg/ dL).
On the occasion, Rajeev Sibal, vice president and head-India region, Ranbaxy, said, “The first phase of this study was on patients who are at risk of heart disease, which has been released. The second phase would focus on heart risks amongst 50,000 plus general population. The study would measure the cardiovascular risk of patients and healthy individuals using an inter-heart risk scoring system. The results would provide doctors useful insights on the risk factors facing Indian patients.”
